TYKERB®(lapatinib)NDC NUMBER CHANGE
- September 16, 2016
- Administrative, Drugs
TYKERB®(lapatinib)NDC NUMBER CHANGE
Former GlaxoSmithKline (fGSK) Products
EFFECTIVE IMMEDIATELY, please note that the current NDC numbers are being replaced by the NEW NDC NUMBERS referenced in Table A below:
Table A:
| Product Name | Old NDC # | New NDC # | Package Size | Package Strength |
| TYKERB® (lapatinib) | 0173-0752-00 | 0078-0671-19 | 150 tablets | 250mg |
Direct Purchasers:Effective immediately, please use the New NDC Numbers for new orders that you submit to Novartis for these brands. We ask that you continue to maintain the old NDC numbers in your system until such time as your inventories have been depleted. Please link the old and new NDC numbers together so when your customers order using the old NDC numbers, it does not generate a backorder or discontinuation notification.
Please continue to distribute your existing inventories for the above-referenced OLD NDC numbers.
All pending backorders are canceled immediately. Please reorder using the NEW NDC Numbers listed in
Table A. The minimum order requirements and pricing have remained the same.
Indirect Purchasers: We ask that you continue to maintain the old NDC numbers in your system until such time as your wholesalers’ inventories have been depleted.
Returns:Please refer to Novartis Returns Policy at ncc.novartis.com.If you have any questions, please contact your account manager or call our Customer Service Department at 1-800-526-0175.
